- Home
- ZYME vs PENG Comparison
ZYME vs PENG Comparison
Compare ZYME & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- PENG
- Stock Information
- Founded
- ZYME 2003
- PENG 1988
- Country
- ZYME United States
- PENG Cayman Islands
- Employees
- ZYME 286
- PENG N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- PENG Semiconductors
- Sector
- ZYME Health Care
- PENG Technology
- Exchange
- ZYME Nasdaq
- PENG Nasdaq
- Market Cap
- ZYME 739.6M
- PENG 908.8M
- IPO Year
- ZYME 2017
- PENG 2017
- Fundamental
- Price
- ZYME $11.53
- PENG $15.88
- Analyst Decision
- ZYME Buy
- PENG Strong Buy
- Analyst Count
- ZYME 6
- PENG 8
- Target Price
- ZYME $19.50
- PENG $24.94
- AVG Volume (30 Days)
- ZYME 833.8K
- PENG 1.1M
- Earning Date
- ZYME 05-08-2025
- PENG 04-02-2025
- Dividend Yield
- ZYME N/A
- PENG N/A
- EPS Growth
- ZYME N/A
- PENG N/A
- EPS
- ZYME N/A
- PENG N/A
- Revenue
- ZYME $76,304,000.00
- PENG $1,318,349,000.00
- Revenue This Year
- ZYME $26.29
- PENG $19.41
- Revenue Next Year
- ZYME $75.78
- PENG $8.94
- P/E Ratio
- ZYME N/A
- PENG N/A
- Revenue Growth
- ZYME 0.38
- PENG 8.05
- 52 Week Low
- ZYME $7.97
- PENG $14.20
- 52 Week High
- ZYME $17.70
- PENG $29.81
- Technical
- Relative Strength Index (RSI)
- ZYME 49.31
- PENG N/A
- Support Level
- ZYME $10.69
- PENG N/A
- Resistance Level
- ZYME $11.48
- PENG N/A
- Average True Range (ATR)
- ZYME 0.78
- PENG 0.00
- MACD
- ZYME 0.10
- PENG 0.00
- Stochastic Oscillator
- ZYME 81.57
- PENG 0.00
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.